← Open Payments lookup

LAVINIA DRAMBAREAN: Open Payments

NPI 1871849372 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$180,189 in 427 payments from 27 companies in 2025. Trend: 2023 $52,652 · 2024 $129,066 · 2025 $180,189

Speaker / faculty: $120,719Travel & lodging: $46,555Food & beverage: $7,933Consulting: $4,735Education: $247
CompanyPaymentsAmount
Janssen Biotech, Inc.65$84,125
Lilly USA, LLC56$31,159
ABBVIE INC.76$21,772
Incyte Corporation32$12,454
Regeneron Healthcare Solutions, Inc.37$11,793
GENZYME CORPORATION17$9,072
Eli Lilly and Company3$3,695
E.R. Squibb & Sons, L.L.C.11$3,002
LEO Pharma Inc.19$1,281
Novartis Pharmaceuticals Corporation23$311

Products named: TREMFYA, DUPIXENT, TALTZ, EBGLYSS, OPZELURA, SKYRIZI, RINVOQ, Sotyktu.

Industry payments across MS — which companies pay providers there.